Shockwave Medical Inc (SWAV)
330.51
+0.51
(+0.15%)
USD |
NASDAQ |
May 03, 15:55
Shockwave Medical Cash from Investing (Quarterly): -242.26M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -242.26M |
September 30, 2023 | -305.88M |
June 30, 2023 | -83.77M |
March 31, 2023 | 6.182M |
December 31, 2022 | -35.28M |
September 30, 2022 | -5.276M |
June 30, 2022 | 5.816M |
March 31, 2022 | -27.41M |
December 31, 2021 | -23.10M |
September 30, 2021 | -4.782M |
June 30, 2021 | 27.21M |
March 31, 2021 | 27.09M |
Date | Value |
---|---|
December 31, 2020 | -153.61M |
September 30, 2020 | 12.11M |
June 30, 2020 | 29.70M |
March 31, 2020 | 4.325M |
December 31, 2019 | 16.79M |
September 30, 2019 | 7.641M |
June 30, 2019 | -83.56M |
March 31, 2019 | -0.42M |
December 31, 2018 | -0.851M |
September 30, 2018 | -0.309M |
June 30, 2018 | -0.506M |
March 31, 2018 | 1.492M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-305.88M
Minimum
Sep 2023
29.70M
Maximum
Jun 2020
-43.58M
Average
-4.782M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
Boston Scientific Corp | -285.00M |
AtriCure Inc | 9.644M |
Masimo Corp | -25.30M |
Perspective Therapeutics Inc | -0.089M |
Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 71.70M |
Cash from Financing (Quarterly) | -0.164M |
Free Cash Flow | 165.46M |
Free Cash Flow Per Share (Quarterly) | 1.661 |
Free Cash Flow to Equity (Quarterly) | 62.64M |
Free Cash Flow to Firm (Quarterly) | 65.94M |
Free Cash Flow Yield | 1.31% |